Previous 10 | Next 10 |
From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...
Historic efforts to develop COVID-19 vaccines have had two huge effects on the industry. Efforts to waive patents on COVID-19 vaccines to help reduce costs for emerging markets are also stuck. Since healthcare is an industry that has a profound impact on society, there’s a ...
Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare
If you were investing heavily in tech/growth stocks over the past 11 years, we wish to congratulate you. We're not here to say that the next 11 years won't be the same, rather to suggest that you should treat your portfolio the same way you treat your body. If you've vaccinated yo...
If two strategies or portfolios are correlated highly enough (higher than 0.84), then their types of risk overlap sufficiently to be part of the same asset class or to serve the same strategic purpose in a portfolio. The demand for acute care has an inelastic demand curve, meaning tha...
I present my 2021 portfolio: 10 stocks that I believe should perform well this year. I explain the rationale behind the picks, esp. the balance between growth, value, speculation, and diversification. The portfolio is up 10% in the first 20 days. Presented are live links for perfo...
In this article I will walk you through the commonly used but wrong way to think about volatility decay. We'll then walk through an example of volatility decay with realistic numbers. Afterwards, we'll build a simple mathematical model to calculate volatility decay from first prin...
Gainers: S&P Biotech Bull 3X Direxion (NYSEARCA: LABU ) +35.9% . More news on: Direxion Daily S&P Biotech Bull 3x Shares ETF, Direxion Shares ETF Trust - Direxion Daily Pharmaceutical & Medical Bull 3X Shares, ProShares Trust II - ProShares Ultra Bloomberg Crude...
Gainers: Direxion S&P Biotech Bull 3X (NYSEARCA: LABU ) +27.4% . More news on: Direxion Daily S&P Biotech Bull 3x Shares ETF, Direxion Daily CSI China Internet Index Bull 2x Shares ETF, ProShares Trust - ProShares Ultra Nasdaq Biotechnology, News on ETFs, Stocks on th...
In my last article titled “ ACADIA: The company perspectives in numbers ”, I described the demographic trends that the company is operating under, listed key near-term catalysts, and made an overview of the company’s development. However, in the comments to the article, I ...
News, Short Squeeze, Breakout and More Instantly...
ProShares Ultra Nasdaq Biotechnology Company Name:
BIB Stock Symbol:
NASDAQ Market:
2024-05-19 12:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-19 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-31 02:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...